Scientific Program

  • September 9 (THU)
  • September 10 (FRI)
09:00-09:10 Opening Ceremony
Symposium 1
09:10 - 11:10 Public health response to COVID-19 Chair :
S1-1 Public health response to COVID-19: National perspective
Hsien-Ho Lin ( National Taiwan University ), Chinese Taipei
S1-2 Public health response to COVID-19: Regional perspective
TBD ( WHO WPRO ),
S1-3 Public health response to COVID-19: Global perspective
Maria Van Kerkhove ( WHO ), Switzerland
S1-4 Strategies to flatten the curve: current evidence and practical pitfalls
Paul Tambyah ( National University Hospital ), Singapore
Symposium 2
09:10 - 11:10 Gram-negative bacteria Chair :
S2-1 Epidemiology and impact of carbapenem-resistant Acinetobacter and Pseudomonas
Po-Ren Hsueh ( National Taiwan University Hospital ), Chinese Taipei
S2-2 Epidemiology and impact of carbapenem-resistant Enterobacterioceae
Anucha Apisarnthanarak ( Thammasat University Hospital ), Thailand
S2-3 Emergence of intrinsically resistant gram-negative bacteria: Stenotrophomonas, Burkholderia, and Chryseobacterium
TBD ( ),
S2-4 Antimicrobial therapy for carbapenem-resistant gram-negative bacteria
Yohei Doi ( University of Pittsburgh ), USA
Symposium 3
09:10 - 11:10 How I treat difficult-to-treat infections (interactive) Chair :
S3-1 How I treat persistent S. aureus bacteremia
Vance Fowler ( Duke Department of Medicine ), USA
S3-2 How I treat vascular graft infections
TBD ( ),
S3-3 How I treat CMV infection in high-risk pediatric patients?
YaeJean Kim ( Samsung Medical Center ), Korea
Plenary Lecture 1
11:10 - 11:50 Chair :
P-1 Pandemic preparedness: are we ready for the future?
Michael T. Osterholm ( University of Minnesota ), USA
Plenary Lecture 2
11:50 - 12:30 Chair :
P-2 Vaccines against SARS-CoV-2
Jerome H. Kim ( International Vaccine Institute )
Korea
Plenary Lecture 3
15:10 - 15:50 Chair :
P-3 Overview of the current status of antimicrobial resistance
David Livermore ( University of East Anglia )
UK
Symposium 4
15:50 - 17:20 Clinical management of COVID-19 Chair :
S4-1 Therapeutic options for COVID-19
Davey Smith ( University of California San Diego ), USA
S4-2 Critical care of patients with severe COVID-19
TBD ( ),
S4-3 Long-term sequelae of COVID-19
Bin Cao ( National Clinical Research Center for Respiratory Diseases ), PR China
Symposium 5
15:50 - 17:20 Diagnostics/clinical microbiology Chair :
S5-1 The future is here: rapid diagnosis of antimicrobial resistance
Robin Patel ( Mayo Clinic ), USA
S5-2 Next-generation sequencing for diagnosis of infectious diseases
TBD ( ),
S5-3 How to combine novel techniques with stewardship: a real-world experience
TBD ( ),
Symposium 6
15:50 - 17:20 Antimicrobial stewardship Chair :
S6-1 Shorter the better: current evidence for the shorter duration of antibiotic therapy
Brad Spellberg ( University of Southern California ), USA
S6-2 Incentives for antimicrobial stewardship: situation in Asia
David Lye ( Tan Tock Seng Hospital ), Singapore
S6-3 Antimicrobial stewardship during the COVID-19 pandemic
Timothy M. Rawson ( Imperial College London ), UK
Symposium 7
09:00 - 11:00 Pros and cons (interactive) Chair :
S7-1 Early oral transition for endocarditis
Pro) TBD (TBD), / Con) Vance Fowler ( Duke Department of Medicine ), USA
S7-2 Piperacillin-tazobactam for ESBL-producing Enterobacterales
Pro) Jesús Rodríguez-Baño ( Universidad de Sevilla ),Spain / Con) Patrick Harris ( The University of Queensland ), Australia
S7-3 Combination regimen for carbapenem-resistant Acinetobacter infections
Pro) TBD (TBD), / Con) Visanu Thamlikitkul ( Mahidol University), Thailand
Symposium 8
09:00 - 11:00 Gram-positive bacteria Chair :
S8-1 Update on antimicrobial resistance of Staphylococcus
Michael Otto ( National Institute of Allergy and Infectious Diseases ), USA
S8-2 Antimicrobial resistance and treatment options for enterococcal infections
Benjamin P. Howden ( University of Melbourne ), Australia
S8-3 How to dose vancomycin: time to go Bayesian?
Michael Rybak ( Wayne State University ), USA
S8-4 Novel therapeutic approaches to bacterial infection
Andrew M. Edwards ( Imperial College London ), UK
Symposium 9
09:00 - 11:00 Infection prevention and control Chair :
S9-1 Airborne, droplet, or something in between: physics of respiratory secretions
Qian Hua ( South East University ), PR China
S9-2 Infection control for COVID-19: theory and practice
Kalisvar Marimuthu ( National Centre for Infectious Diseases ), Singapore
S9-3 Environmental cleaning & disinfection: current controversies
Stephan Harbarth ( Geneva University Hospital ), Switzerland
S9-4 Outbreak control in healthcare settings
Doo Ryeon Chung ( Samsung Medical Center ), Korea
Plenary Lecture 4
11:10 - 11:50 Chair :
P-4 TBD
Robin Patel ( Mayo Clinic ), USA
Plenary Lecture 5
11:50 - 12:30 Chair :
P-5 Promoting the development of novel therapeutic agents
Dennis M. Dixon ( National Institute of Allergy and Infectious Diseases ), USA
Plenary Lecture 6
15:10 - 15:50 Chair :
P-6 Designing and conducting clinical trials that change the practice
David Paterson ( University of Queensland ), Australia
Symposium 10
15:50 - 17:20 Fungus Chair :
S10-1 Epidemiology and impact of anti-fungal resistance in Asia
Ban Hock Tan ( Singapore General Hospital ), Singapore
S10-2 The confluence between viral and fungal infections
Monica Slavin ( The University of Melbourne ), Australia
S10-3 Novel therapeutic options for invasive fungal infections
David W. Denning ( The University of Manchester and Global Action Fund for Fungal Infections ), UK
Symposium 11
15:50 - 17:20 Vaccine Chair :
S11-1 Future role of vaccines on antibacterial resistance
TBD ( TBD ),
S11-2 Novel technologies for vaccine development
Kaitlyn M. Morabito ( DMID, NIAID, NIH ), USA
S11-3 Ensuring vaccine safety: surveillance for adverse events
TBD ( TBD ),
Symposium 12
15:50 - 17:20 HIV Chair :
S12-1 Aging and non-communicable diseases in people living with HIV
TBD ( ),
S12-2 Diagnosis and Treatment of Multi-Drug Resistant HIV
Roy M. Gulick ( Weill Cornell Medicine ), USA
S12-3 Disparities in PrEP access in the Asia Pacific
Shui Shan Lee ( The Chinese University of Hong Kong ), Hong Kong, China